10-Q: DSS Inc. Reports Q1 2025 Results: Revenue Up, Losses Persist Amid Strategic Shifts

DSS Inc. reports a 28% increase in revenue for Q1 2025 compared to Q1 2024, but continues to experience net losses.

Summary

• DSS Inc. reported its Q1 2025 financial results, showing a revenue increase of 28% compared to the same period in 2024, reaching $4.954 million.
• The company's net loss for the quarter was $5.296 million, slightly higher than the $5.109 million loss in Q1 2024.
• Printed products revenue increased by 30%, driven by new and existing customer orders.
• Rental income from the Securities and Investment Management segment increased by 79% due to new tenants at the AMRE LifeCare Pittsburg facility.
• Net investment income decreased by 79% due to loans going on non-accrual status.
• Commission revenue decreased by 27% due to a change in clearing houses, but is expected to improve.
• The company sold its Plano, TX facility for $9.5 million, resulting in a loss of $684,000.
• Operating expenses increased due to a bonus awarded to Heng Fai Holdings Limited.
• The company is taking steps to sell real estate holdings and reduce expenses to improve its financial position.
• As of March 31, 2025, the company had approximately $10.8 million in cash and cash equivalents.
• The company has identified material weaknesses in its internal controls and is implementing a remediation plan.

Sentiment

Score: 4

Explanation: The document presents mixed signals. Revenue is up, which is positive, but losses persist and there are concerns about liquidity and internal controls. The outlook is uncertain.

Positives

• Total revenue increased by 28% compared to the same period last year.
• Printed products revenue increased by 30% due to new customer orders.
• Rental income increased by 79% due to new tenants at AMRE LifeCare Pittsburg facility.
• The company finalized the sale of its Plano, Tx. Facility for a gross sales price of $ 9,500,000.
• The company is taking steps to sell real estate holdings and reduce expenses to improve its financial position.

Negatives

• The company experienced a net loss of $5.296 million, slightly higher than the $5.109 million loss in Q1 2024.
• Net investment income decreased by 79% due to loans going on non-accrual status.
• Commission revenue decreased by 27% due to a change in clearing houses.
• The company recorded a loss of $684,000 on the sale of its Plano, TX facility.
• The company has identified material weaknesses in its internal controls.

Risks

• The company's ability to continue as a going concern is dependent on generating operating cash, selling marketable securities, and reducing expenses.
• The company has a history of operating losses and negative cash flows.
• Several notes receivable are on non-accrual status, impacting net investment income.
• The company has identified material weaknesses in its internal controls, which could affect the reliability of financial reporting.
• The company is in default on certain loan agreements.

Future Outlook

The company believes it will have access to sources of capital from the sale of its equity securities and debt financing, and thus believes that it has sufficient cash to meet its cash requirements for at least the next 12 months from the filing date of this Quarterly Report.

Industry Context

The company operates in several distinct business lines, including product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing, reflecting a diversified approach to revenue generation.

Comparison to Industry Standards

• It is difficult to compare DSS Inc.'s results directly to industry standards due to its diversified business model.
• For the product packaging segment, key competitors include companies like WestRock and International Paper, which have significantly larger revenue bases and more established market positions.
• In the biotechnology sector, DSS Inc.'s Impact BioMedical operates in a highly competitive landscape with numerous companies focused on drug discovery and development.
• The commercial lending segment faces competition from traditional banks and non-bank financial institutions.
• The securities and investment management segment competes with established broker-dealers and asset management firms.

Related Party Transactions

• The Company owns 127,179,291 shares or approximately 4 % of the outstanding shares of Alset International Limited (Alset Intl), a company incorporated in Singapore and publicly listed on the Singapore Exchange Limited.
• On September 10, 2020, the Companys wholly owned subsidiary DSS Securities, Inc. entered into membership interest purchase agreement with BMI Financial Group, Inc. a Delaware corporation (BMIF) and BMI Capital International LLC, a Texas limited liability company (BMIC) whereas DSS Securities, Inc. purchased 14.9 % membership interests in BMIC for $ 100,000 .
• On August 29, 2022, DSS Financial Management Inc and BMI Capital, Inc. (BMIC), a related party, entered into a promissory note (Note 8) in the principal sum of $ 100,000 with interest of 8 %, is due in three quarterly installments beginning on September 14, 2022.
• On May 8, 2023, DSS Financial Management Inc and BMIC entered into a promissory note (Note 9) in the principal sum of $ 102,000 with interest at the prime rate plus 2 % ( 10.5 % at September 30, 2024 and December 31, 2023) with a maturity date of May 7, 2026 .
• On July 26, 2022, APF and VEII, Inc. (VEII) entered into a promissory note (Note 10) in the principal sum of $ 1,000,000 with interest of 8 % with all unpaid principal and interest due on July 26, 2024 .
• On October 13, 2021, LVAM entered into loan agreement with BMIC (BMIC Loan), a related party, whereas LVAM borrowed the principal amount of $ 3,000,000 , with interest to be charged at a variable rate to be adjusted at the maturity date.
• On October 13, 2021, LVAM entered into a loan agreement with Lee Wilson Tsz Kin (Wilson Loan), a related party, whereas LVAM borrowed the principal amount of $ 3,000,000 , with interest to be charged at a variable rate to be calculated at the maturity date.
• On February 6, 2025, as a bonus for compensation awarded to Heng Fai Holdings Limited (HFHL), a Hong Kong Company, which is beneficially owned by Mr. Heng Fai Ambrose Chan, Director of DSS, Inc., and pursuant to DSS, Incs. 2020 Employee, Director and Consultant Equity Incentive Plan (the Plan), HFHL was awarded 1,000,000 shares of the Companys common stock under the Plan, for services rendered.

Stakeholder Impact

• Shareholders: The company's continued losses and concerns about its ability to continue as a going concern could negatively impact shareholder value.
• Employees: The company's cost-cutting measures could potentially impact employees.
• Customers: The company's ability to maintain its operations and provide services to customers could be affected by its financial challenges.
• Creditors: The company's default on certain loan agreements could negatively impact creditors.

Next Steps

• The company intends to generate operating cash through the sale of marketable securities and real estate holdings.
• The company will continue to take measures to materially reduce expenses and cash burn at all corporate and business line levels.
• The company will continue to implement its remediation plan to address material weaknesses in internal controls.

Key Dates

Keywords

financial results, revenue, net loss, printed products, rental income, commercial lending, biotechnology, securities, investment management, financial statements, liquidity, capital resources, internal controls, going concern